Calidi Biotherapeutics, Inc.
AMEX: CLDI0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange American
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Eric E. Poma
- Employees
- 28
- Headquarters
- San Diego, United States
- IPO year
- 2021
- Market cap
- $1.2M
- Website
- https://calidibio.com
Loading CLDI…
Loading profile data…Frequently asked questions about CLDI
What does Calidi Biotherapeutics, Inc. (CLDI) do?
Calidi Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on immuno-oncology, dedicated to developing advanced immunotherapies for various cancers. The company's innovative approach centers on utilizing powerful, allogeneic (donor-derived) stem cells as specialized carriers for anti-tumor agents. This technology is being adv...
Where does CLDI trade?
Calidi Biotherapeutics, Inc. (CLDI) trades on the New York Stock Exchange American.
What sector is CLDI in?
Calidi Biotherapeutics, Inc. (CLDI) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Calidi Biotherapeutics, Inc.?
Eric E. Poma is the chief executive officer of Calidi Biotherapeutics, Inc. (CLDI).
Where is Calidi Biotherapeutics, Inc. headquartered?
Calidi Biotherapeutics, Inc. is headquartered in United States.
Does CLDI pay a dividend?
Calidi Biotherapeutics, Inc. (CLDI) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CLDI go public?
Calidi Biotherapeutics, Inc. (CLDI) completed its initial public offering in 2021.